PL

Piere-Etienne Chabrier De Lassauniere

IS Ipsen Pharma S.A.S.: 3 patents #32 of 146Top 25%
IL Ipsen Biopharm Limited: 1 patents #30 of 71Top 45%
Overall (All Time): #1,502,815 of 4,157,543Top 40%
3
Patents All Time

Issued Patents All Time

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
9259458 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy Christine Favre, Michel Auguet 2016-02-16
8784841 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy Christine Favre, Michel Auguet 2014-07-22
7838009 Use of botulinum toxin for the preparation of a medicament for the treatment of lithiasis of salivary gland, gall bladder, kidney, or pancreas Pierre D'Arbigny, Alan Barcock 2010-11-23